Our blog

What Life Science Start-ups Can Learn From Sports Managers
What Life Science Start-ups Can Learn From Sports Managers
by Andrew Maddison
Posted in Biopharma
Particularly in big sports leagues, managers may have hundreds of millions to play with when it comes to building their team. But, without wise investment in the right team, a big budget may not translate into results.... so what can start-ups learn from sports teams?
Read more
Addressing the post-Brexit hiring challenges of UK Qualified Persons
Addressing the post-Brexit hiring challenges of UK Qualified Persons
by Christine Sands
Posted in Biopharma
Before Brexit, the UK could hire QPs from any location within the EU, but now we can only hire QPs based in the UK – resulting in a lack of supply and a rise in day-rates and salaries. We spoke to the Vice President of Quality at a global biotechnology organisation about the challenges of hiring QPs within the UK, and how these might be overcome.
Read more
Attracting and Retaining Talent during the Life Science Talent Turnover Tsunami
Attracting and Retaining Talent during the Life Science Talent Turnover Tsunami
by Christine Sands
Posted in Biopharma, Life Science & Diagnostics, MedTech & Devices
In the US, we are beginning to see the start of the predicted ‘turnover tsunami’ and it might not be long until we see something similar across Europe and the UK. But why is this happening and what can employers do to not only retain existing employees but to also attract those individuals looking for a change of career?
Read more
CASE STUDY: Generic Pharma Company’s US Expansion
CASE STUDY: Generic Pharma Company’s US Expansion
by Christine Sands
Posted in Biopharma, Case Studies
An established pharmaceutical company in Europe that develops, manufactures and markets generic medications planned to continue its growth strategy by opening a new subsidiary to target the US generics market. To develop and commercialise a portfolio of generic drugs to market, the company needed a US General Manager.
Read more
Will Covid-19 Increase US Biosimilar Adoption in 2021?
Will Covid-19 Increase US Biosimilar Adoption in 2021?
by Christine Sands
Posted in Biopharma
In 2019, the US biosimilar market was worth $737.2 million and continues to grow with a CAGR of 46.2% forecast for 2020-2027, however many are frustrated at the current rate of adoption in the US. But with increasing healthcare costs and a growing debt from Covid-19, what does the next year hold for biosimilar adoption across the US?
Read more
Interview with Rachel McNeill | Founder & CEO | PharmaPhix
Interview with Rachel McNeill | Founder & CEO | PharmaPhix
by Christine Sands
Posted in Biopharma, Female Leaders Series
As part of our ‘Female Leaders: Inspiring Together’ series, we interviewed Rachel McNeill – Founder & CEO at PharmaPhix – about her new pharma services company and why she feels society’s biggest challenge is accepting that we all have an equal role in balancing work and family life regardless of gender.
Read more
Interview with Emmanuelle Lepine | General Manager | mAbxience
Interview with Emmanuelle Lepine | General Manager | mAbxience
by Christine Sands
Posted in Biopharma, Female Leaders Series
As part of our ‘Female Leaders: Inspiring Together series, we interviewed Emmanuelle Lepine – General Manager at mAbxience – about becoming a CEO of a pharma company before the age of 40 and how she learnt the hard way not to push yourself past your limits.
Read more